MGS Pharma

Active

Private limited companyfounded 2024active for 2 yearsRue des Longues Pièces 17, 4970 Stavelot, BelgiumKBO/BCE: BE 1014.761.540

Summary

MGS Pharma has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €54,552 and a net result of €54,885. Its solvency ranks better than 87% of 22,650 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow Report Compare

MGS PharmaActiveChecked score 93/100

Risk analysis Report Compare

History

MGS Pharma was incorporated on 7 October 2024 as a private limited company by one natural person, with a starting capital of €500.¹² Since 2024, MAGIS Louise Anne Marie has served as director of the company.² The company has filed annual accounts once, for financial year 2025.³

Acts, filings and financial milestones

All 2Gazette 1Filings 1

2026

24-04

NBB filing Annual accounts filed

financial year 2025 · micro format

2024

09-10

Gazette deed Incorporation

Appointment: MAGIS Louise Anne Marie (director) · Permanent representative: MAGIS Louise Anne Marie · Founding capital9 facts ▸

Incorporation, 04-10-2024
Founding capital, €500
Capital
Capital conversion, “compte de capitaux propres disponible” (deed in French)
Registered office clause, “4970 Francorchamps, rue des Longues Pièces”, 17 (deed in French)
Director appointment, MAGIS Louise Anne Marie (director (not named in the articles))
Permanent representative, MAGIS Louise Anne Marie
Pre-incorporation commitments, “takeover, tous les engagements ainsi que les obligations qui en résultent, et toutes les activités entreprises au nom et pour compte de la société en formation” (deed in French)
Power of attorney

Gazette deedNBB filing

1 of 1 deed read